Cargando…

肺鳞癌驱动基因研究进展

Background and objective Lung cancer is the leading cause of cancer-related deaths worldwide. Next to adenocarcinoma, squamous cell carcinoma (SCC) of the lung is the most frequent histologic subtype in non-small cell lung cancer. Several molecular alterations have been defined as " driver onco...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 中国肺癌杂志编辑部 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000441/
https://www.ncbi.nlm.nih.gov/pubmed/24854563
http://dx.doi.org/10.3779/j.issn.1009-3419.2014.05.13
_version_ 1783331726441840640
collection PubMed
description Background and objective Lung cancer is the leading cause of cancer-related deaths worldwide. Next to adenocarcinoma, squamous cell carcinoma (SCC) of the lung is the most frequent histologic subtype in non-small cell lung cancer. Several molecular alterations have been defined as " driver oncogenes" responsible for both the initiation and maintenance of the malignancy. The squamous cell carcinoma of the lung has recently shown peculiar molecular characteristics which relate with both carcinogenesis and response to targeted drugs. So far, about 40% of lung squamous cell carcinoma has been found harbouring driver oncogenes, in which fibroblast growth factor receptor 1 (FGFR1) plays important roles. In this review, we will report the mainly advances on some latest driver mutations of squamous cell lung cancer.
format Online
Article
Text
id pubmed-6000441
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher 中国肺癌杂志编辑部
record_format MEDLINE/PubMed
spelling pubmed-60004412018-07-06 肺鳞癌驱动基因研究进展 Zhongguo Fei Ai Za Zhi 综述 Background and objective Lung cancer is the leading cause of cancer-related deaths worldwide. Next to adenocarcinoma, squamous cell carcinoma (SCC) of the lung is the most frequent histologic subtype in non-small cell lung cancer. Several molecular alterations have been defined as " driver oncogenes" responsible for both the initiation and maintenance of the malignancy. The squamous cell carcinoma of the lung has recently shown peculiar molecular characteristics which relate with both carcinogenesis and response to targeted drugs. So far, about 40% of lung squamous cell carcinoma has been found harbouring driver oncogenes, in which fibroblast growth factor receptor 1 (FGFR1) plays important roles. In this review, we will report the mainly advances on some latest driver mutations of squamous cell lung cancer. 中国肺癌杂志编辑部 2014-05-20 /pmc/articles/PMC6000441/ /pubmed/24854563 http://dx.doi.org/10.3779/j.issn.1009-3419.2014.05.13 Text en 版权所有©《中国肺癌杂志》编辑部2014 https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 3.0) License. See: https://creativecommons.org/licenses/by/3.0/
spellingShingle 综述
肺鳞癌驱动基因研究进展
title 肺鳞癌驱动基因研究进展
title_full 肺鳞癌驱动基因研究进展
title_fullStr 肺鳞癌驱动基因研究进展
title_full_unstemmed 肺鳞癌驱动基因研究进展
title_short 肺鳞癌驱动基因研究进展
title_sort 肺鳞癌驱动基因研究进展
topic 综述
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000441/
https://www.ncbi.nlm.nih.gov/pubmed/24854563
http://dx.doi.org/10.3779/j.issn.1009-3419.2014.05.13
work_keys_str_mv AT fèilínáiqūdòngjīyīnyánjiūjìnzhǎn
AT fèilínáiqūdòngjīyīnyánjiūjìnzhǎn